HLI:NYSEHoulihan Lokey, Inc. Analysis
Data as of 2026-04-08 - not real-time
$142.87
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Houlihan Lokey is trading around $142.9, well below its 20‑day ($141.0), 50‑day ($156.5) and 200‑day ($180.8) moving averages, indicating a bearish price environment. The stock sits just above the technical support at $134.4 and faces resistance near $149.6. Momentum is mixed – the RSI at 42 suggests neutral pressure while the MACD has turned bullish, offering a modest upside catalyst. Volatility is elevated at over 27% for the past 30 days, and volume trends are decreasing, flagging liquidity concerns. Fundamentally, the firm posts a 13% revenue growth, exceptional gross margins (~95%), and a solid ROE of ~20%, with a dividend yield of 1.71% backed by a 36% payout ratio. A DCF model values the shares at roughly $187, implying ~32% upside from current levels, though the PE multiple (21.9x) exceeds the industry average (16.8x). Recent material news notes a slowdown in restructuring activity—a key revenue segment—while the firm is bolstering its Capital Solutions group with senior hires and has filed a prospectus supplement for a potential secondary offering.
Overall, the stock appears undervalued relative to its intrinsic estimate, supported by strong profitability and sustainable dividends, but short‑term price pressure and sector‑specific headwinds suggest a cautious approach until technical signs of a reversal solidify.
Overall, the stock appears undervalued relative to its intrinsic estimate, supported by strong profitability and sustainable dividends, but short‑term price pressure and sector‑specific headwinds suggest a cautious approach until technical signs of a reversal solidify.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price remains below key moving averages, indicating bearish momentum
- MACD bullish crossover provides limited upside potential
- Decreasing volume and high 30‑day volatility raise liquidity concerns
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value suggests ~30% upside
- Sustainable dividend yield of 1.71% enhances total return
- Strategic hires in Capital Solutions may revive restructuring revenue
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consistently high gross margins and strong ROE indicate durable profitability
- Low leverage (debt‑to‑equity ~22) and solid cash position support financial stability
- Dividend sustainability and attractive payout ratio provide steady income
Key Metrics & Analysis
Financial Health
Revenue Growth13.00%
Profit Margin16.91%
P/E Ratio21.9
ROE20.47%
ROA12.08%
Debt/Equity21.67
P/B Ratio4.3
Op. Cash Flow$769.5M
Industry P/E16.8
Technical Analysis
TrendBearish
RSI41.9
Support$134.41
Resistance$149.59
MA 20$141.03
MA 50$156.50
MA 200$180.76
MACDBullish
VolumeDecreasing
Fear & Greed Index85.05
Valuation
Fair Value$187.02
Target Price$189.50
Upside/Downside32.64%
GradeUndervalued
TypeBlend
Dividend Yield1.71%
Risk Assessment
Beta0.93
Volatility27.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.